Copper peptides are short protein fragments bound to a copper ion
Studies have investigated NNMT inhibition in the context of obesity, metabolic dysfunction, lipid accumulation, and energy-expenditure models, with research also exploring effects on adipocyte differentiation and methylation pathways
Full normalization is more likely when underlying contributors like excess body fat, poor sleep, inflammatory diets, and chronic stress are addressed alongside treatment
For individuals who dont have a B12 deficiency, the energy boost might be subtle
In terms of documented efficacy, this is not a close comparison: GLP-1 S has shown weight reductions in the range of 13-20% of body weight in clinical trials, while AOD-9604s pivotal trial failed to demonstrate a significant effect at that scale